Ultrasound Guided Femoral Nerve Block

Description

The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.

Conditions

Hip Fracture

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.

Comparison of Ultrasound Guided Femoral Nerve Blockade and Standard Parenteral Opioid Pain Management Alone in Patients With Hip Fracture in the Emergency Department

Ultrasound Guided Femoral Nerve Block

Condition
Hip Fracture
Intervention / Treatment

-

Contacts and Locations

Boston

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States, 02215

Worcester

St. Vincent's Hospital, Worcester, Massachusetts, United States, 01608

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients over 18 years of age presenting to the ED with radiographically established intra-, extracapsular hip fracture, able to consent and participate in the study and who have moderate to severe pain (numerical pain score \>= 31) at the time of enrollment.
  • * Patients with a previous history of hypersensitivity to local anesthetics,
  • * Patients who have signs of a local infection at the site of planned needle placement.
  • * INR \> 1.4NOAC use within 48 hours
  • * Prophylactic Low-Molecular Weight Heparin (LMWH) within 12 hours
  • * Therapeutic LMWH within 24 hours
  • * Prophylactic Unfractionated Heparin (5000 Units BID or TID) within 6 hours

Ages Eligible for Study

18 Years to 101 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Beth Israel Deaconess Medical Center,

Beatrice Hoffmann, MD PhD, PRINCIPAL_INVESTIGATOR, Beth Israel Deaconess Medical

Study Record Dates

2026-12